vs

Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $59.7M, roughly 1.4× Cipher Mining Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -1229.6%, a 1252.4% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 41.4%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-695.9M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 11.4%).

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

CIFR vs FDMT — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.4× larger
FDMT
$85.1M
$59.7M
CIFR
Growing faster (revenue YoY)
FDMT
FDMT
+8508858.6% gap
FDMT
8508900.0%
41.4%
CIFR
Higher net margin
FDMT
FDMT
1252.4% more per $
FDMT
22.8%
-1229.6%
CIFR
More free cash flow
FDMT
FDMT
$724.3M more FCF
FDMT
$28.5M
$-695.9M
CIFR
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
11.4%
CIFR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIFR
CIFR
FDMT
FDMT
Revenue
$59.7M
$85.1M
Net Profit
$-734.2M
$19.4M
Gross Margin
59.4%
Operating Margin
-503.4%
17.3%
Net Margin
-1229.6%
22.8%
Revenue YoY
41.4%
8508900.0%
Net Profit YoY
-4293.1%
139.1%
EPS (diluted)
$-1.91
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIFR
CIFR
FDMT
FDMT
Q4 25
$59.7M
$85.1M
Q3 25
$71.7M
$90.0K
Q2 25
$43.6M
$15.0K
Q1 25
$49.0M
$14.0K
Q4 24
$42.2M
$1.0K
Q3 24
$24.1M
$3.0K
Q2 24
$36.8M
$5.0K
Q1 24
$48.1M
$28.0K
Net Profit
CIFR
CIFR
FDMT
FDMT
Q4 25
$-734.2M
$19.4M
Q3 25
$-3.3M
$-56.9M
Q2 25
$-45.8M
$-54.7M
Q1 25
$-39.0M
$-48.0M
Q4 24
$17.5M
Q3 24
$-86.8M
$-43.8M
Q2 24
$-15.3M
$-35.0M
Q1 24
$39.9M
$-32.4M
Gross Margin
CIFR
CIFR
FDMT
FDMT
Q4 25
59.4%
Q3 25
62.7%
Q2 25
64.8%
Q1 25
69.6%
Q4 24
56.9%
Q3 24
37.5%
Q2 24
61.2%
Q1 24
69.2%
Operating Margin
CIFR
CIFR
FDMT
FDMT
Q4 25
-503.4%
17.3%
Q3 25
-52.5%
-67983.3%
Q2 25
-103.9%
-396373.3%
Q1 25
-77.8%
-383007.1%
Q4 24
40.5%
Q3 24
-379.2%
-1704400.0%
Q2 24
-43.9%
-849120.0%
Q1 24
97.2%
-136200.0%
Net Margin
CIFR
CIFR
FDMT
FDMT
Q4 25
-1229.6%
22.8%
Q3 25
-4.6%
-63195.6%
Q2 25
-105.1%
-364386.7%
Q1 25
-79.6%
-342657.1%
Q4 24
41.5%
Q3 24
-359.9%
-1461433.3%
Q2 24
-41.5%
-699060.0%
Q1 24
82.9%
-115717.9%
EPS (diluted)
CIFR
CIFR
FDMT
FDMT
Q4 25
$-1.91
$0.43
Q3 25
$-0.01
$-1.01
Q2 25
$-0.12
$-0.98
Q1 25
$-0.11
$-0.86
Q4 24
$0.04
Q3 24
$-0.26
$-0.79
Q2 24
$-0.05
$-0.63
Q1 24
$0.13
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIFR
CIFR
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$628.3M
$402.7M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$805.5M
$505.7M
Total Assets
$4.3B
$566.7M
Debt / EquityLower = less leverage
3.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIFR
CIFR
FDMT
FDMT
Q4 25
$628.3M
$402.7M
Q3 25
$1.2B
$305.1M
Q2 25
$62.7M
$293.2M
Q1 25
$23.2M
$321.4M
Q4 24
$5.6M
$424.9M
Q3 24
$25.3M
$501.9M
Q2 24
$122.6M
$541.9M
Q1 24
$88.7M
$525.9M
Total Debt
CIFR
CIFR
FDMT
FDMT
Q4 25
$2.7B
Q3 25
$1.0B
Q2 25
$167.1M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CIFR
CIFR
FDMT
FDMT
Q4 25
$805.5M
$505.7M
Q3 25
$783.2M
$369.0M
Q2 25
$748.9M
$420.9M
Q1 25
$734.8M
$469.7M
Q4 24
$682.0M
$510.6M
Q3 24
$672.0M
$552.9M
Q2 24
$690.8M
$588.3M
Q1 24
$600.9M
$600.6M
Total Assets
CIFR
CIFR
FDMT
FDMT
Q4 25
$4.3B
$566.7M
Q3 25
$2.8B
$424.0M
Q2 25
$1.0B
$473.6M
Q1 25
$913.8M
$515.7M
Q4 24
$855.4M
$560.4M
Q3 24
$775.4M
$604.0M
Q2 24
$775.6M
$620.1M
Q1 24
$677.1M
$629.9M
Debt / Equity
CIFR
CIFR
FDMT
FDMT
Q4 25
3.37×
Q3 25
1.31×
Q2 25
0.22×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIFR
CIFR
FDMT
FDMT
Operating Cash FlowLast quarter
$-207.9M
$28.6M
Free Cash FlowOCF − Capex
$-695.9M
$28.5M
FCF MarginFCF / Revenue
-1165.4%
33.5%
Capex IntensityCapex / Revenue
817.1%
0.1%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-1.1B
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIFR
CIFR
FDMT
FDMT
Q4 25
$-207.9M
$28.6M
Q3 25
$-50.1M
$-46.5M
Q2 25
$-56.2M
$-43.4M
Q1 25
$-47.2M
$-47.8M
Q4 24
$-87.5M
$-134.6M
Q3 24
$-6.5M
$-29.4M
Q2 24
$-25.4M
$-30.2M
Q1 24
$-26.6M
$-29.1M
Free Cash Flow
CIFR
CIFR
FDMT
FDMT
Q4 25
$-695.9M
$28.5M
Q3 25
$-256.2M
$-46.6M
Q2 25
$-87.5M
$-43.4M
Q1 25
$-71.8M
$-48.4M
Q4 24
$-227.0M
$-138.4M
Q3 24
$-83.2M
$-31.2M
Q2 24
$-33.2M
$-30.6M
Q1 24
$-34.5M
$-29.8M
FCF Margin
CIFR
CIFR
FDMT
FDMT
Q4 25
-1165.4%
33.5%
Q3 25
-357.3%
-51765.6%
Q2 25
-200.9%
-289620.0%
Q1 25
-146.7%
-345635.7%
Q4 24
-537.6%
-13837100.0%
Q3 24
-345.0%
-1038966.7%
Q2 24
-90.2%
-611840.0%
Q1 24
-71.7%
-106421.4%
Capex Intensity
CIFR
CIFR
FDMT
FDMT
Q4 25
817.1%
0.1%
Q3 25
287.5%
101.1%
Q2 25
71.8%
440.0%
Q1 25
50.2%
4507.1%
Q4 24
330.4%
378600.0%
Q3 24
317.8%
59266.7%
Q2 24
21.4%
6980.0%
Q1 24
16.4%
2535.7%
Cash Conversion
CIFR
CIFR
FDMT
FDMT
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
-5.00×
Q3 24
Q2 24
Q1 24
-0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons